More: RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
More: RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
Original post: T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
Read the original post: Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana/SFWJ Advances as Leading Infrastructure Supplier for Colombia’s Top Flower Producers
See the rest here: Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
Read the original post: ImPact Biotech to Present Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at Upcoming Medical Conferences
Read more here: Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary
The rest is here: ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting
Here is the original post: Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Read more from the original source: Immunocore announces upcoming presentation and posters at ASCO 2024
Go here to see the original: Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual...
Recent Comments